In October 2025, the Plasma Protein Therapeutic Association (PPTA) held their Plasma Protein Forum. Our North America Chair, Steven Spitalnik was one of the session speakers. The session “Driving Awareness & Action for Anti-D” provided a thought-provoking discussion between experts, patients, and donors on the global challenges and opportunities shaping its future. The discussion focused […]
Category: News
Thank you to the International Society of Blood Transfusion (ISBT)
WIRhE gratefully acknowledges the International Society of Blood Transfusion (ISBT) for awarding their financial support of our upcoming event focused on Rh disease and maternal health (Event ID: 2025J-06). This support enables important dialogue among clinicians, researchers, advocates, and partners working to address Rh disease globally. The programme will include focused discussion on Rh immunoglobulin […]
WIRhE’s First Newsletter
We are delighted to be sharing our first newsletter of the work we have done these last months. This could not have been done without our incredible partners – who work tirelessly for their communities, and are always open to having meaningful conversations about what a partnership means and how we can best work together […]
Publication on the Major causes and associated factors of anemia among neonates, Ethiopia
Abate AT, Bazezew LY, Abuhay AG, Siyoum TM, Tadesse G, Lakew AM, Gedefaw GD. Major causes and associated factors of anemia among neonates admitted to the five comprehensive and specialized hospitals of Northwest Amhara region in Ethiopia (2023): Cross sectional study. Journal of Neonatal Nursing. 2025 Dec 1;31(6):101743. This paper is available by open access […]
Partnership Spotlight: Eldon Biologicals
WIRhE is grateful to Eldon Biologicals for their strategic support of our foundation coordination and regional development work. Eldon’s support will enable WIRhE to strengthen its core organisational capacity during a critical phase of growth. This funding directly supports the work of the Executive Director, ensuring continuity across partnerships, regional initiatives, communications, and advocacy efforts […]
WHO Approval of Point of Care test for ABO and Blood Typing
As a result of the fourth meeting of the World Health Organization (WHO) Strategic Advisory Group of Experts on In Vitro Diagnostics in 2022, a decision was made to recommend a point-of-care test (i.e., the EldonCard), developed and marketed by Eldon Biologicals, to determine an individual’s ABO blood type and Rh(D) status in the context […]